bf/NYSE:MOH_icon.jpeg

COM:MOLINAHEALTHCARE

Molina Healthcare

  • Stock

USD

Last Close

296.07

22/11 21:00

Market Cap

16.82B

Beta: -

Volume Today

708.08K

Avg: -

Company Overview

Metric
Company NameMolina Healthcare, Inc.HAO Turar Healthcare
SymbolMOH
MSH IDCOM:MOLINAHEALTHCAREKZ:TURAR
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - Healthcare PlansHealthcare
CountryUSKZ
Stage
Employee Count18K
Websitemolinahealthcare.comturar.kz
LinkedIn
Founders

Market Metrics

Metric
Market Cap16.82B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue34.07B
Revenue (LTM)
Revenue (NTM)
Gross Profit4.33B
EBITDA1.74B
Operating Income1.57B
Net Income1.09B
EPS18.91
Diluted EPS18.77
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.35
Operating Profit Margin0.05
EBITDA Margin0.05
Net Profit Margin0.03
Return on Equity0.29
Return on Assets0.07
Return on Capital Employed0.23

Valuation Multiples

Metric
P/E Ratio21.85
P/B Ratio5.24
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.71
EV Multiple15.36

Operational Metrics

Metric
Days Sales Outstanding27.01
Days Payables Outstanding13.74
Days Inventory Outstanding
Operating Cycle33.25
Cash Conversion Cycle17.89
Asset Turnover2.46

Cash Flow Metrics

Metric
Operating Cash Flow1.66B
Free Cash Flow1.58B
Cash Flow to Debt0.69
Operating Cash Flow/Sales0.05
Free Cash Flow Yield0.10

Balance Sheet Metrics

Metric
Cash & Equivalents4.85B
Accounts Receivable
Inventory
Goodwill1.24B
Debt to Capitalization0.36
Debt to Assets0.09
Current Ratio1.47
Quick Ratio2.54

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.00
R&D to Revenue
SG&A to Revenue0.07